T ScientificLtd Balance Sheet Health
Financial Health criteria checks 5/6
T ScientificLtd has a total shareholder equity of ₩130.6B and total debt of ₩12.7B, which brings its debt-to-equity ratio to 9.7%. Its total assets and total liabilities are ₩174.0B and ₩43.4B respectively.
Key information
9.7%
Debt to equity ratio
₩12.70b
Debt
Interest coverage ratio | n/a |
Cash | ₩13.95b |
Equity | ₩130.55b |
Total liabilities | ₩43.43b |
Total assets | ₩173.98b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A057680's short term assets (₩31.0B) do not cover its short term liabilities (₩40.7B).
Long Term Liabilities: A057680's short term assets (₩31.0B) exceed its long term liabilities (₩2.7B).
Debt to Equity History and Analysis
Debt Level: A057680 has more cash than its total debt.
Reducing Debt: A057680's debt to equity ratio has reduced from 19.1% to 9.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A057680 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A057680 is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.